Inventor
Jesse M. Jaynes
Inventor
Raleigh, NC, US
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
C07KPeptides27%
C12NMicroorganisms or enzymes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
A01KAnimal husbandry4%
Y02ATechnologies for adaptation to climate change4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
C12YEnzymes3%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,083,775Transgenic corn with antifungal peptide AGM182 USDA (DN:0113.18)202110,548,944Antimicrobial peptides and methods of using the same202010,413,584Peptides having immunomodulatory properties201910,149,886Peptides having anti-inflammatory properties201810,017,542Antimicrobial peptides and methods of use thereof201810,016,480Peptide-based methods for treating pancreatic cancer20189,492,499'Peptides having anti-inflammatory properties'20169,487,560'Angiogenic active lytic peptides'20169,163,066'Antimicrobial lytic peptides'20158,734,775'Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments'20148,461,118'Lytic peptides having anti-proliferative activity against prostate cancer cells'20138,258,100'Ligand/lytic peptide methods of use'20127,803,755'Molecules for the treatment and prevention of fungal diseases'20107,566,777'Genes encoding hormone and lytic peptides'20096,680,058'Compositions and methods for contraception in or sterilization of mammals'20046,635,740'Ligand/lytic peptide compositions and methods of use'20036,559,281'Non-naturally occurring synthetic lytic peptides'20036,514,692'Method for treatment of immunodeficiency virus infection'20036,440,935'Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides'20026,303,568'Therapeutic antimicrobial polypeptides, their use and methods for preparation'20016,255,282'Lytic peptides'20016,191,110'Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides'20016,084,156'Plants producing lytic peptides'20006,018,102'Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same'20006,001,805'Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides'19995,968,904'Modified arginine containing lytic peptides and method of making the same by glyoxylation'19995,962,410'Inhibition of eucaryotic pathogens with lytic peptides'19995,955,573'Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same'19995,861,478'Lytic peptides'19995,811,654'Plants genetically enhanced for nutritional quality'19985,773,413'Method of combating mammalian neoplasias, and lytic peptides therefor'19985,744,445'Method of treating pulmonary disease states with non-naturally occuring amphipathic peptides'19985,717,064'Methylated lysine-rich lytic peptides and method of making same by reductive alkylation'19985,597,946'Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor'19975,597,945'Plants genetically enhanced for disease resistance'19975,561,107'Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides'19965,352,607'Molecular clone of a chitinase gene from vibrio parahemolyticus'19944,517,008'Compositions containing and methods of use of an infectivity-cured Hr plasmid-bearing microorganism'19854,425,150'Compositions containing and methods of use of an infectivity-cured Hr plasmid-bearing microorganism'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–1985Based in Bozeman, MT, US· patent location history
1994–2012Patents assigned to UNIV LOUISIANA STATE (7)· patent assignee history
1994–2004Based in Baton Rouge, LA, US· patent location history
1996–1998Patents assigned to DEMETER BIOTECH LTD (4)· patent assignee history
1996–2012Based in Raleigh, NC, US· patent location history
1999–2003Patents assigned to DEMEGEN INC (8)· patent assignee history
1999–2002Patents assigned to HELIX BIOMEDIX INC (5)· patent assignee history
2010–2021Based in Auburn, AL, US· patent location history
2016–2020Patents assigned to RIPTIDE BIOSCIENCE INC (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DEMEGEN INC | 8 | 1999–2003 |
| UNIV LOUISIANA STATE | 7 | 1994–2012 |
| RIPTIDE BIOSCIENCE INC | 6 | 2016–2020 |
| HELIX BIOMEDIX INC | 5 | 1999–2002 |
| DEMETER BIOTECH LTD | 4 | 1996–1998 |
Locations
| Location | Patents | Span |
|---|---|---|
| Raleigh, NC, US | 13 | 1996–2012 |
| Auburn, AL, US | 12 | 2010–2021 |
| Baton Rouge, LA, US | 12 | 1994–2004 |
| Bozeman, MT, US | 2 | 1984–1985 |